Small cell lung cancer (SCLC) is a fast-growing cancer that forms in the lung. It's one of two types of lung cancer. The other type is non-small cell lung cancer (NSCLC). SCLC is less common than ...
Small cell lung cancer, or SCLC, is aggressive, lethal and particularly cruel because chemotherapy initially works so well. But within just a few months, SCLC becomes resistant to drugs and dashes ...
HER2-mutated non-small-cell lung cancer (NSCLC) is a rare form of lung cancer where the cancer cells have a mutation that makes them grow and divide in an uncontrolled way. You can best understand ...
ZL-1310, targeting DLL3, shows early antitumor activity in extensive-stage SCLC, with 74% of patients experiencing tumor shrinkage or disappearance. The FDA's fast track designation for ZL-1310 ...
Hosted on MSN
Oncologist explains different types of lung cancers and which 1 'tends to progress more rapidly than others'
Lung cancer is the leading cause of cancer-related deaths worldwide, accounting for the highest mortality rates among both men and women, as per World Health Organisation. In an interview with HT ...
Please provide your email address to receive an email when new articles are posted on . Patients with small cell lung cancer who had higher levels of detectable ctDNA mutations at diagnosis had worse ...
Tarlatamab is a bispecific T-cell engager (BiTE) that binds to delta-like ligand-3 (DLL3) on small cell lung cancer (SCLC) cells and cluster of differentiation-3 on T cells, thereby delivering ...
Alveltamig is a trispecific T-cell engager, enhancing immune response by linking T cells to cancer cells with three binding arms. The trial addresses treatment challenges for small cell lung cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results